Browsing Tag
Nasdaq AMPH
1 post
FDA clears Amphastar Pharmaceuticals’ teriparatide injection, opening a new growth pathway in osteoporosis treatment
Find out how FDA approval of Amphastar Pharmaceuticals’ teriparatide injection opens a new growth pathway in the U.S. osteoporosis treatment market.